The Oncology Institute, Inc. (TOI) reported Q3 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $65 million versus the consensus estimate of $68.91 million.
GUIDANCE:
The Oncology Institute, Inc. sees FY2022 revenue of $245-250 million, versus the consensus of $270.3 million.